Transformation or trouble? Research into MDMA plagued with allegations of misconduct

https://www.npr.org/sections/health-shots/2024/05/13/ [login to see] /ecstasy-mdma-ptsd-fda-approval
In a matter of months, the Food and Drug Administration is expected to decide whether the drug commonly known as ecstasy can be used as a treatment for post-traumatic stress disorder.

An approval by the agency would represent an enormous milestone for the movement to bring psychedelics into the mainstream of mental health care. An FDA rejection of MDMA, the abbreviation of the drug's chemical name, would deal a major setback to the effort.